{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:13:27Z","timestamp":1758046407369,"version":"3.44.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.pharma.2012.03.002","type":"journal-article","created":{"date-parts":[[2012,4,13]],"date-time":"2012-04-13T08:47:38Z","timestamp":1334306858000},"page":"120-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exploration biologique des drogues illicites et des m\u00e9dicaments psychotropes en milieu professionnel"],"prefix":"10.1016","volume":"70","author":[{"given":"P.","family":"Mura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Saussereau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-P.","family":"Goull\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"unstructured":"Consommation de drogues illicites en milieu professionnel\u00a0: \u00e9tat des lieux des connaissances et des recherches men\u00e9es en France, note no\u00a02010-9, 14\u00a0juin 2010, observatoire fran\u00e7ais des drogues et toxicomanies.","key":"10.1016\/j.pharma.2012.03.002_bib0005"},{"unstructured":"Lhermitte, Haguenoer (ce num\u00e9ro) \u00e0 compl\u00e9ter par l\u2019\u00e9diteur.","key":"10.1016\/j.pharma.2012.03.002_bib0010"},{"unstructured":"Ordonnance no\u00a02010-49\u00a0du 13\u00a0janvier 2010\u00a0relative \u00e0 la biologie m\u00e9dicale. JO no\u00a012\u00a0du 15\u00a0janvier 2010, page 819.","key":"10.1016\/j.pharma.2012.03.002_bib0015"},{"key":"10.1016\/j.pharma.2012.03.002_bib0020","first-page":"345","article-title":"Accidentologie et drogues illicites","volume":"186","author":"Mura","year":"2002","journal-title":"Bull Acad Natl Med"},{"issue":"8","key":"10.1016\/j.pharma.2012.03.002_bib0025","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/anatox\/35.8.541","article-title":"Detection of delta-9-tetrahydrocannabinol in exhaled breath collected from cannabis users","volume":"35","author":"Beck","year":"2011","journal-title":"J Anal Toxicol"},{"issue":"5","key":"10.1016\/j.pharma.2012.03.002_bib0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/jat\/34.5.233","article-title":"Amphetamines detected in exhaled breath from drug addicts: a new possible method for drugs of abuse testing","volume":"34","author":"Beck","year":"2010","journal-title":"J Anal Toxicol"},{"doi-asserted-by":"crossref","unstructured":"Mura P, Kintz P. Drogues et accidentalit\u00e9. Chapitre\u00a0: d\u00e9pistage urinaire. Cirimele V, Pelissier-Alicot AL. EDP Sciences 2011.","key":"10.1016\/j.pharma.2012.03.002_bib0035","DOI":"10.3917\/edp.mura.2011.01.0003"},{"key":"10.1016\/j.pharma.2012.03.002_bib0040","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/jat\/22.6.460","article-title":"In vivo adulteration: excess fluid causes false-negative marijuana and cocaine urine test results","volume":"22","author":"Cone","year":"1998","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.pharma.2012.03.002_bib0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cccn.2004.01.003","article-title":"Comparison of spot tests with AdultaCheck 6\u00a0and Intect 7\u00a0urine tests strips for detecting the presence of adulterants in urine specimens","volume":"348","author":"Dasgupta","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharma.2012.03.002_bib0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1051\/ata\/2002038","article-title":"Passer \u00e0 travers les tests de d\u00e9pistage\u00a0: substitution, dilution, adult\u00e9ration des urines et des cheveux","volume":"14","author":"Dumestre-Toulet","year":"2002","journal-title":"Ann Toxicol Anal"},{"doi-asserted-by":"crossref","unstructured":"Mura P, Kintz P. Drogues et accidentalit\u00e9. Chapitre\u00a0: le d\u00e9pistage salivaire. Verstraete A. EDP Sciences 2011.","key":"10.1016\/j.pharma.2012.03.002_bib0055","DOI":"10.3917\/edp.mura.2011.01.0003"},{"doi-asserted-by":"crossref","unstructured":"Mura P, Kintz P. Drogues et accidentalit\u00e9. Chapitre\u00a0: aspects l\u00e9gaux et r\u00e9glementaires en France et en Europe. Arditti J, Vertsraete A, Kuhlmann. EDP Sciences 2011.","key":"10.1016\/j.pharma.2012.03.002_bib0060","DOI":"10.3917\/edp.mura.2011.01.0003"},{"key":"10.1016\/j.pharma.2012.03.002_bib0065","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1373\/clinchem.2008.118638","article-title":"Chemoinformatic methods for predicting interference in drug of abuse\/toxicology immunoassays","volume":"55","author":"Krasowski","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.pharma.2012.03.002_bib0070","first-page":"35","article-title":"\u00c9valuation de six tests rapides pour le d\u00e9pistage du cannabis dans la sueur, la salive et les urines\u00a0: corr\u00e9lation avec la GC-MS","volume":"1","author":"Mura","year":"1999","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.pharma.2012.03.002_bib0075","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.forsciint.2006.01.020","article-title":"Oral fluid testing for cannabis: on-site Oraline IV s.a.t. device versus GC\/MS","volume":"161","author":"Cirimele","year":"2006","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.pharma.2012.03.002_bib0080","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1051\/ata:2007025","article-title":"Int\u00e9r\u00eat du triage TOX drug screen pour le d\u00e9pistage urinaire de drogues illicites et de m\u00e9dicaments","volume":"19","author":"Mura","year":"2007","journal-title":"Ann Toxicol Anal"},{"key":"10.1016\/j.pharma.2012.03.002_bib0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/FTD.0b013e3181947916","article-title":"Evaluation of the Cozart DDSV test for cannabis in oral fluid","volume":"31","author":"Kintz","year":"2009","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pharma.2012.03.002_bib0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.forsciint.2009.10.012","article-title":"Evaluation of on-site oral fluid screening using Drugwipe-5(+), RapidSTAT and Drug Test 5000\u00a0for the detection of drugs of abuse in drivers","volume":"198","author":"Wille","year":"2010","journal-title":"Forensic Sci Int"},{"issue":"3","key":"10.1016\/j.pharma.2012.03.002_bib0095","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/jat\/34.3.155","article-title":"Detection of delta-9-tetrahydrocannabinol and amphetamine-type stimulants in oral fluid using the Rapid Stat point-of-collection drug-testing device","volume":"34","author":"R\u00f6hrich","year":"2010","journal-title":"J Anal Toxicol"},{"issue":"4","key":"10.1016\/j.pharma.2012.03.002_bib0100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/anatox\/35.4.211","article-title":"An evaluation of on-site oral fluid drug screening devices DrugWipe5+ and Rapid STAT using oral fluid for confirmation analysis","volume":"35","author":"Pehrsson","year":"2011","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.pharma.2012.03.002_bib0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.forsciint.2010.11.026","article-title":"An analytical evaluation of eight on-site drug screening devices using laboratory confirmation results from oral fluid","volume":"208","author":"Blencowe","year":"2011","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.pharma.2012.03.002_bib0110","first-page":"745","article-title":"Cannabis and Nifluril\u00ae","volume":"60","author":"Forzy","year":"2002","journal-title":"Ann Biol Clin"},{"key":"10.1016\/j.pharma.2012.03.002_bib0115","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1051\/ata:2005020","article-title":"D\u00e9pistage du cannabis dans les urines\u00a0: attention \u00e0 l\u2019acide niflumique","volume":"17","author":"Delacour","year":"2005","journal-title":"Ann Toxicol Anal"},{"issue":"3","key":"10.1016\/j.pharma.2012.03.002_bib0120","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/FTD.0b013e3182126d08","article-title":"Crossreactivity of bupropion metabolite with enzyme-linked immunosorbent assays designed to detect amphetamine in urine","volume":"33","author":"Reidy","year":"2011","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pharma.2012.03.002_bib0125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/jat\/19.2.84","article-title":"A labetolol metabolite with analytical characteristics resembling amphetamines","volume":"19","author":"Gilbert","year":"1995","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.pharma.2012.03.002_bib0130","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/AOG.0b013e318206c07c","article-title":"False-positive amphetamine toxicology screen results in three pregnant women using labetalol","volume":"117","author":"Yee","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.pharma.2012.03.002_bib0135","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1001\/jama.286.24.3115","article-title":"Quinolones and false-positive urine screening for opiates by immunoassay technology","volume":"286","author":"Baden","year":"2001","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.pharma.2012.03.002_bib0140","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1345\/aph.1D632","article-title":"False-positive urine opiate screening associated with fluoroquinolone use","volume":"38","author":"Zacher","year":"2004","journal-title":"Ann Pharmacother"},{"doi-asserted-by":"crossref","unstructured":"Mura P, Kintz P. Drogues et accidentalit\u00e9. Chapitre\u00a0: r\u00e9ponses aux questions les plus souvent pos\u00e9es. Mura P. EDP Sciences 2011.","key":"10.1016\/j.pharma.2012.03.002_bib0145","DOI":"10.3917\/edp.mura.2011.01.0003"},{"key":"10.1016\/j.pharma.2012.03.002_bib0150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/jat\/19.6.450","article-title":"Drug-testing in the workplace: could a positive test for one of the mandated drugs be for reasons other than illicit use of the drug","volume":"19","author":"elSohly","year":"1995","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.pharma.2012.03.002_bib0155","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/jat\/27.7.449","article-title":"The determination of morphine in urine and oral fluid following ingestion of poppy seeds","volume":"27","author":"Rohrig","year":"2003","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.pharma.2012.03.002_bib0160","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.legalmed.2009.03.002","article-title":"Effect of poppy seed consummation on the positive results of opiates screening in biological samples","volume":"11","author":"Jankovicova","year":"2009","journal-title":"Leg Med"},{"key":"10.1016\/j.pharma.2012.03.002_bib0165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0379-0738(01)00538-2","article-title":"Delta(9) - THC, 11-OH-Delta (9) -THC and Delta (9)-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people","volume":"123","author":"Giroud","year":"2001","journal-title":"Forensic Sci Int"},{"issue":"2","key":"10.1016\/j.pharma.2012.03.002_bib0170","first-page":"29","article-title":"Identification et dosage des cannabino\u00efdes dans le sang total","volume":"8","author":"Kintz","year":"1996","journal-title":"Toxicorama"},{"doi-asserted-by":"crossref","unstructured":"Goull\u00e9 JP, Paschal L, Lesieur M, Danger P, Lacroix C. Application de la GC-MS\/MS \u00e0 la technique de dosage des cannabino\u00efdes sanguins recommand\u00e9e par la SFTA. 13\u00e8me Congr\u00e8s de la Soci\u00e9t\u00e9 Fran\u00e7aise de Toxicologie Analytique. Pau, 8\u201310\u00a0juin 2005. Ann Toxicol Anal. 2005; 17(3):169 [R\u00e9sum\u00e9].","key":"10.1016\/j.pharma.2012.03.002_bib0175","DOI":"10.1051\/ata:2005016"},{"doi-asserted-by":"crossref","unstructured":"Mura P, Kintz P. Drogues et accidentalit\u00e9. Chapitre\u00a0: dosages sanguins et urinaires. Saussereau E, Goull\u00e9 J.P., Lacroix C, Ricordel I. EDP Sciences 2011.","key":"10.1016\/j.pharma.2012.03.002_bib0180","DOI":"10.3917\/edp.mura.2011.01.0003"},{"key":"10.1016\/j.pharma.2012.03.002_bib0185","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pharma.2008.07.006","article-title":"Pharmacocin\u00e9tique du delta-9-t\u00e9trahydrocannabinol (THC)","volume":"66","author":"Goull\u00e9","year":"2008","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.pharma.2012.03.002_bib0190","series-title":"Marihuana and medicine","first-page":"91","article-title":"Absorption, distribution and biotransformation of the cannabinnoids","author":"Harvey","year":"1999"},{"key":"10.1016\/j.pharma.2012.03.002_bib0195","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/jat\/16.5.276","article-title":"Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THC-COOH during and after smoking marijuana","volume":"16","author":"Huestis","year":"1992","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.pharma.2012.03.002_bib0200","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jat\/31.5.288","article-title":"Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid","volume":"31","author":"Kauert","year":"2007","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.pharma.2012.03.002_bib0205","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jat\/16.5.283","article-title":"Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of 9-tetrahydrocannabinol (THCCOOH)","volume":"16","author":"Huestis","year":"1992","journal-title":"J Anal Toxicol"},{"unstructured":"Daldrup T. Cannabis im Strassenverkehr Avschlussbericht des im Auftrage des Ministeriums f\u00fcr Wirtschaft und mittelstand Technologie und Verkenhr des Landes Nordrhein-Westfalen durchgef\u00fchrten untersuchungsvorhabens. 1996; 44\u201359.","key":"10.1016\/j.pharma.2012.03.002_bib0210"},{"key":"10.1016\/j.pharma.2012.03.002_bib0215","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jat\/20.6.441","article-title":"Urinary exception profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked dose of marijuana","volume":"20","author":"Huestis","year":"1996","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.pharma.2012.03.002_bib0220","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jat\/23.5.323","article-title":"Urinary excretion of 11-nor-carboxy-delta 9-tetrahydrocannabinol and cannabino\u00efdes and in frequent and infrequent drug users","volume":"23","author":"Smith-Kielland","year":"1999","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.pharma.2012.03.002_bib0225","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0379-0738(00)00437-0","article-title":"Time of drug elimination in chronic drug abusers. Case study of 52 patients in a low-step detoxication ward","volume":"119","author":"Reiter","year":"2001","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.pharma.2012.03.002_bib0230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00427321","article-title":"Behavioral pharmacokinetics of marijuana","volume":"85","author":"Barnett","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharma.2012.03.002_bib0235","first-page":"155","article-title":"Concentration-effect relationship of delta-9-tetrahydrocannabiol and prediction of psychotropic effects after smoking marijuana","volume":"35","author":"Harder","year":"1997","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.pharma.2012.03.002_bib0240","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/clpt.1980.181","article-title":"Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking","volume":"28","author":"Ohlsson","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharma.2012.03.002_bib0245","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00007691-199312000-00013","article-title":"Relating blood concentrations of t\u00e9trahydrocannabinol and metabolites to pharmacologic effects and time of marijuana usage","volume":"15","author":"Cone","year":"1993","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pharma.2012.03.002_bib0250","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0379-0738(03)00052-5","article-title":"Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subject: results of a French collaborative study","volume":"133","author":"Mura","year":"2003","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.pharma.2012.03.002_bib0255","first-page":"51","article-title":"Drug concentrations and traffic safety","volume":"2","author":"McBay","year":"1986","journal-title":"Alcohol Drugs Driving"},{"key":"10.1016\/j.pharma.2012.03.002_bib0260","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/jat\/29.8.842","article-title":"THC can be detected in brain while absent in blood","volume":"29","author":"Mura","year":"2005","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.pharma.2012.03.002_bib0265","series-title":"Coca\u00efne in toxicology et pharmacology m\u00e9dicol\u00e9gales.","first-page":"431","author":"Ragoucy Senger","year":"1998"},{"key":"10.1016\/j.pharma.2012.03.002_bib0270","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.forsciint.2007.11.009","article-title":"Concentrations of cocaine and its major metabolite benzoylecgonine in blood samples from apprehended drivers in Sweden","volume":"177","author":"Jones","year":"2008","journal-title":"Forensic Sci Int"},{"issue":"2","key":"10.1016\/j.pharma.2012.03.002_bib0275","first-page":"17","article-title":"Identification et dosage de la benzoylecgonine, coca\u00efne, m\u00e9thylecgonine-ester, cod\u00e9ine, morphine et 6-ac\u00e9tylmorphine dans le sang total","volume":"8","author":"Gaillard","year":"1999","journal-title":"Toxicorama"},{"unstructured":"Commission contr\u00f4le de qualit\u00e9 de la soci\u00e9t\u00e9 fran\u00e7aise de toxicologie analytique. www. Sfta.org.","key":"10.1016\/j.pharma.2012.03.002_bib0280"},{"issue":"1","key":"10.1016\/j.pharma.2012.03.002_bib0285","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jat\/25.1.69","article-title":"Rapid confirmation\/quantitation of ecgonine methyl ester, benzoylecgonine, and cocaine in urine using on-line extraction coupled with fast HPLC and tandem mass spectrometry","volume":"25","author":"Jeanville","year":"2001","journal-title":"J Anal Toxicol"},{"issue":"1","key":"10.1016\/j.pharma.2012.03.002_bib0290","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1051\/ata:2008004","article-title":"Quantification des opiac\u00e9s, coca\u00efniques et amph\u00e9taminiques par chromatographie liquide haute performance\/spectrom\u00e9trie de masse en tandem apr\u00e8s pr\u00e9paration en ligne de l\u2019\u00e9chantillon","volume":"20","author":"Lacroix","year":"2008","journal-title":"Ann Toxicol Anal"},{"key":"10.1016\/j.pharma.2012.03.002_bib0295","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/jat\/31.8.462","article-title":"Cocaine metabolites urinary excretion after controlled smoked administration","volume":"31","author":"Huestis","year":"2007","journal-title":"J Anal Toxicol"},{"issue":"15","key":"10.1016\/j.pharma.2012.03.002_bib0300","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1002\/rcm.2035","article-title":"On-line desalting and determination of morpnine, morphine-3-glucuronide and morphine-6-glucuronide in microdialysis and plasma samples using column switching and liquid chromatography tandem mass spectrometry","volume":"19","author":"Bengtsson","year":"2005","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"7","key":"10.1016\/j.pharma.2012.03.002_bib0305","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/jms.1436","article-title":"A high-througput multicomponent screening method for diuretic, masking agents, central nervous system (CNS) stimulants and opiates in human urine by UPLC-MS\/MS","volume":"43","author":"Th\u00f6rngren","year":"2008","journal-title":"J Mass Spectrom"},{"unstructured":"Rifflet A, Richeval C, Humbert L, Orkild AM, Legeleux O, Lhermitte M. Analyse ultrarapide des d\u00e9riv\u00e9s amph\u00e9taminiques, des opiac\u00e9s, de la coca\u00efne et ses m\u00e9tabolites par UPLC-MS\/MS apr\u00e8s une simple extraction SPE dans du sang total. SFTA, juin 2006, Le Touquet, France.","key":"10.1016\/j.pharma.2012.03.002_bib0310"},{"issue":"Suppl. 2","key":"10.1016\/j.pharma.2012.03.002_bib0315","first-page":"5133","article-title":"Opioid pharmacology","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"issue":"11","key":"10.1016\/j.pharma.2012.03.002_bib0320","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1093\/clinchem\/47.11.1980","article-title":"Concentration ratios of morphine to codeine in blood of impaired drivers as evidence of heroin use and not medication with codeine","volume":"47","author":"Ceder","year":"2001","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.pharma.2012.03.002_bib0325","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/jat\/25.7.504","article-title":"Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin","volume":"25","author":"Smith","year":"2001","journal-title":"J Anal Toxicol"},{"unstructured":"Baselt RC. Disposition of toxics drugs on chemicals in human. Biomedical publications, 2008, 8\u00e8me edition.","key":"10.1016\/j.pharma.2012.03.002_bib0330"},{"issue":"2","key":"10.1016\/j.pharma.2012.03.002_bib0335","first-page":"23","article-title":"Identification et dosage des principales drogues amph\u00e9taminiques dans le sang total par chromatographie en phase gazeuse coupl\u00e9e \u00e0 la spectrom\u00e9trie de masse","volume":"8","author":"Marquet","year":"1996","journal-title":"Toxicorama"},{"key":"10.1016\/j.pharma.2012.03.002_bib0340","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1196\/annals.1384.038","article-title":"Methamphetamine disposition in oral fluid, plasma, and urine","volume":"1098","author":"Huestis","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharma.2012.03.002_bib0425","first-page":"241","article-title":"Expertises judiciaires \u00e0 partir d\u2019\u00e9chantillons de cheveux","volume":"38","author":"Kintz","year":"1995","journal-title":"J Med Leg Droit Med"},{"key":"10.1016\/j.pharma.2012.03.002_bib0350","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/0248-8663(96)82686-5","article-title":"Un nouveau moyen d\u2019investigation biologique\u00a0: l\u2019analyse des cheveux. Int\u00e9r\u00eat en pratique m\u00e9dicale","volume":"17","author":"Goull\u00e9","year":"1996","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.pharma.2012.03.002_bib0355","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1051\/ata\/2003012","article-title":"D\u00e9cret no\u00a02003-293 du 31 mars 2003. Restitution de permis de conduire \u00e0 partir d\u2019analyses de cheveux","volume":"15","author":"Kintz","year":"2003","journal-title":"Ann Toxicol Anal"},{"key":"10.1016\/j.pharma.2012.03.002_bib0360","first-page":"5","article-title":"Consensus sur l\u2019analyse des substances organiques dans les cheveux","volume":"6","author":"Goull\u00e9","year":"1994","journal-title":"Toxicorama"},{"issue":"3","key":"10.1016\/j.pharma.2012.03.002_bib0365","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/jat\/28.3.190","article-title":"Evaluation of the DrugCheck 9 on-site immunoassay test cup according to a standard method validation protocol","volume":"28","author":"Taylor","year":"2004","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.pharma.2012.03.002_bib0370","article-title":"Performance of three point-of-care urinalysis test devices for drugs of abuse and therapeutic drugs applied in the emergency department","author":"Attema-de Jonge","year":"2011","journal-title":"J Emerg Med"},{"key":"10.1016\/j.pharma.2012.03.002_bib0375","first-page":"150","article-title":"Evaluation du triage 8 pour le d\u00e9pistage des stup\u00e9fiants et m\u00e9dicaments psychotropes dans les urines de 163 conducteurs impliqu\u00e9s dans un accident corporel et de 33 patients toxicomanes","volume":"13","author":"Mura","year":"2001","journal-title":"Ann Toxicol Annal"},{"key":"10.1016\/j.pharma.2012.03.002_bib0380","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0379-0738(01)00451-0","article-title":"A comparison between on-site immunoassay drug-testing devices and laboratory results","volume":"121","author":"Gr\u00f6nholm","year":"2001","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.pharma.2012.03.002_bib0385","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/jat\/22.3.254","article-title":"Buflomedil is a potent interfering substance in immunoassays of tricyclic antidepressants","volume":"22","author":"Mura","year":"1998","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.pharma.2012.03.002_bib0390","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.forsciint.2004.11.023","article-title":"Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges","volume":"150","author":"Verstraete","year":"2005","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.pharma.2012.03.002_bib0395","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.forsciint.2007.05.022","article-title":"Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood","volume":"175","author":"Pehrsson","year":"2008","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.pharma.2012.03.002_bib0400","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1542\/peds.32.5.940","article-title":"Phenylketonuria and the Guthrie test","volume":"32","author":"Lesser","year":"1963","journal-title":"Pediatrics"},{"doi-asserted-by":"crossref","unstructured":"Saussereau E, Lacroix C, Goull\u00e9 JP. Dosage des opiac\u00e9s, amph\u00e9tamines et coca\u00efniques \u00e0 partir de spots de sang par LC-MS\/MS coupl\u00e9e \u00e0 une pr\u00e9paration en ligne des \u00e9chantillons. Congr\u00e8s de la Soci\u00e9t\u00e9 Fran\u00e7aise de Toxicologie Analytique, Antibes, 9\u201310\u00a0juin 2010.","key":"10.1016\/j.pharma.2012.03.002_bib0405","DOI":"10.1051\/ata\/2010015"},{"key":"10.1016\/j.pharma.2012.03.002_bib0410","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0378-4347(93)80500-4","article-title":"Monitoring of benzodiazepines (clobazam, diazepam and their main active metabolites) in human plasma by coloumn-switching high-performance liquid chromatography","volume":"617","author":"Lacroix","year":"1993","journal-title":"J Chromatogr"},{"key":"10.1016\/j.pharma.2012.03.002_bib0415","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/rcm.346","article-title":"Evalution of several solid phase extraction liquid chromatography\/tandem mass spectrometry on-line configuration for high-troughput analysis of acidic and basic drugs in rat plasma","volume":"15","author":"Mallet","year":"2001","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.pharma.2012.03.002_bib0420","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/1099-0801(200010)14:6<422::AID-BMC25>3.0.CO;2-I","article-title":"High-troughput quantitative bioanalysis by LC\/MS\/MS","volume":"14","author":"Jemal","year":"2000","journal-title":"Biomed Chromatogr"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450912000326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450912000326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:29:43Z","timestamp":1757719783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450912000326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0003450912000326"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2012.03.002","relation":{},"ISSN":["0003-4509"],"issn-type":[{"type":"print","value":"0003-4509"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration biologique des drogues illicites et des m\u00e9dicaments psychotropes en milieu professionnel","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2012.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}